355 participants
An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2016-11-02
- Start Date:
- 2011-11-30
- Completion:
- 2015-02-28
Conditions
- Non-Squamous Non-Small Cell Lung Cancer
No Results Yet